Increasing Prevalence of Metabolic Syndrome in a Chinese Elderly Population: 2001-2010

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Miao ^a   Wang, Jianhua ^a   Jiang, Bin ^a   Sun, Dongling ^a   Wu, Lei ^a   Yang, Shanshan ^a   Wang, Yiyan ^a   Li, Xiaoying ^a   He, Yao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DYSLIPIDEMIA; FEMALE; GERIATRIC PATIENT; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PREVALENCE; PUBLIC HEALTH; SEX DIFFERENCE; TREND STUDY; MIDDLE AGED;

ADULT; AGED; CHINA; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84879184517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066233     Document Type: Article

References (21)

1. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132.
2. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. (2007) Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49: 403-414.
3. Galassi A, Reynolds K, He J, (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119: 812-819.
4. Ford ES, Li C, Sattar N, (2008) Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31: 1898-1904.
5. Lorenzo C, Williams K, Gonzalez-Villalpando C, Haffner SM, (2005) The prevalence of the metabolic syndrome did not increase in Mexico City between 1990-1992 and 1997-1999 despite more central obesity. Diabetes Care 28: 2480-2485.
6. Lim S, Shin H, Song JH, Kwak SH, Kang SM, et al. (2011) Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 34: 1323-1328.
7. Hu G, Lindstrom J, Jousilahti P, Peltonen M, Sjoberg L, et al. (2008) The increasing prevalence of metabolic syndrome among Finnish men and women over a decade. J Clin Endocrinol Metab 93: 832-836.
8. Mozumdar A, Liguori G, (2011) Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 34: 216-219.
9. Gu D, Reynolds K, Wu X, Chen J, Duan X, et al. (2005) Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 365: 1398-1405.
10. Zhao J, Pang ZC, Zhang L, Gao WG, Wang SJ, et al. (2011) Prevalence of metabolic syndrome in rural and urban Chinese population in Qingdao. J Endocrinol Invest 34: 444-448.
11. Villegas R, Xiang YB, Yang G, Cai Q, Fazio S, et al. (2009) Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men. Metab Syndr Relat Disord 7: 37-45.
12. Cai H, Huang J, Xu G, Yang Z, Liu M, et al. (2012) Prevalence and determinants of metabolic syndrome among women in Chinese rural areas. PLoS One 7: e36936.
13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
14. He Y, Jiang B, Wang J, Feng K, Chang Q, et al. (2006) Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 47: 1588-1594.
15. Wu Z, Yao C, Zhao D, Wu G, Wang W, et al. (2001) Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation 103: 462-468.
16. Popkin BM, Horton S, Kim S, Mahal A, Shuigao J, (2001) Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev 59: 379-390.
17. Wang Y, Mi J, Shan XY, Wang QJ, Ge KY, (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31: 177-188.
18. Hu FB, (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34: 1249-1257.
19. He J, Gu D, Reynolds K, Wu X, Muntner P, et al. (2004) Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 110: 405-411.
20. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380: 581-590.
21. Gong P, Liang S, Carlton EJ, Jiang Q, Wu J, et al. (2012) Urbanisation and health in China. Lancet 379: 843-852.